About RI Technologies

RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector. We emphasize on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology & Healthcare industry, tracking market trends, and forecasting industry based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging technologies in areas of discovery, design and development.

Research As Good as the Methodology is!

Gauging Competitive Intelligence Identifying Key Growth Areas and Opportunities Understanding Geographic Relevance to Product Knowing Regional Market Sizes and Growth Opportunities and Restraints Keeping Tab on Emerging Technologies Equity Analysis Tapping New Markets

COPYRIGHT
The copyright and publication rights to all RI Technologies' reports and other products are the property of the company. Plagiarism of any kind accounts to violation of copyright laws. Any type of reproduction of the material without express permission is not allowed. The buyer, under no circumstances, shall license, resell or repackage, or sell data without prior permission of the company.

DISCLAIMER
RI Technologies sells content in good faith. The company is not liable to the buyer for any implications arising out of the usage of data for any particular purpose. The company makes no representations or warranties for the accuracy or completeness of the data. While extreme caution and effort is practiced for data compilation and presentation, the company does not accept any responsibility for findings in the study which are a cumulative effort of primary and secondary research resources. The studies do not endorse or promote any product or company. RI Technologies, its affiliates, partners, distributors, and contractors are not liable for inaccuracies or incompleteness of the reports. User discretion is recommended for the usage of the data.
MIR005 Stem Cell Research A Market Insight Report, January 2011 RI Technologies, www.researchimpact.com Sample Page - 1

II. REPORT SYNOPSIS FOREWORD

STEM CELLS
Stem cells are highly capable of dividing into different types of cells in the body. The stem cell theory implies the unlimited division of the cell in order to replenish other cells of a live person or an animal. Hence the stem cell plays a role of a kind of repair system in a body. Each new cell formed is capable of converting either into a different type of cell with special features such as a brain cell or a muscle cell or remain as a stem cell. The science of stem cells is leading to evolution of cell-based therapies referred to as reparative or regenerative medicine for the treatment of diseases. The ongoing research on stem cells indicates the replenishment of damaged cells by healthy cells in adult organism and the origin of an organism through a single cell. Stem cell science is predicted to be the most promising field in Biology though it has its own share of queries and controversies. This report analyzes the prevalent stem cell technologies and the therapeutic areas in which stem cells find their applications. Synopsis chapter of the report gives the summary of total stem cells market by stem cell type/category, by technology and by therapeutic area at global level and for each of the geographic regions - North America, Europe, Asia-Pacific and Rest of World. Segmentation of Stem Cells Global stem cells market is segmented by - Stem Cell Types into Adult Stem Cells, Embryonic Stem Cells and Cord Blood Stem Cells; by Technology into SC Transplantation, CB Genomics, Xenotransplantation, Cord Blood Banking and Other; and by Therapeutic Area into Neurological, Bone and Cartilage, Cancer, Hematology, Cardiology, Dermatology, Diabetes and Other. Exhibit: Segmentation of Global Stem Cells Market by Stem Cell Type, Technology, and Therapeutic Area
Stem Cell Type Adult Stem Cells Embryonic Stem Cells Cord Blood Stem Cells Technology SC Transplantation Cell Based Genomics Xenotransplantation Cord Blood Banking Other Therapeutic Area Neurology Bone and Cartilage Cancer Hematology Cardiology Dermatology Diabetes *Other
RIT, 2011 MIR005 Stem Cell Research A Market Insight Report, January 2011 RI Technologies, www.researchimpact.com Sample Page - 2

*Other includes Parkinsons, Alzheimers and Renal Diseases

MIR005 Stem Cell Research A Market Insight Report, January 2011 RI Technologies, www.researchimpact.com Sample Page - 3

GLOBAL MARKET ANALYSIS

Global Stem Cells market is projected to reach about US$ XX.XX billion by 2015 from an estimated US$ XX.XX billion in 2009, growing at a robust compounded annual growth rate (CAGR) of XX.XX % during the analysis period 2005-2015. Exhibit: Stem Cells Global Value Market Estimations & Predictions (20052015) in US$ Million
Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 CAGR% RIT Figures, 2011 Value XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX

Xenotransplantation The term Xenotransplantation refers to the transplantation or transferring of living cells, tissues, or organs from one species to another; for example grafting from pigs to humans. The tissues, cells, or organs that are used for the purpose are called xenografts or xenotransplants. Allotransplantation refers to transplantation that is done within the same species.

Market Overview Global market for Xenotransplantation is projected to reach US$ XX.XX billion by 2015 from an estimated US$ XX.XX billion in 2009 by growing at a CAGR of XX.XX % during the period 2005-2015. Asia-Pacific is projected to be the fastest growing market with a growth rate compounded annually at XX.XX % during the above analysis period. North America represents the largest market with an estimated market of US$ XX.XX million accounting for about XX.XX % in 2009.

MIR005 Stem Cell Research A Market Insight Report, January 2011 RI Technologies, www.researchimpact.com Sample Page - 4

Exhibit: Xenotransplantation Global Value Market Estimations & Predictions (2005-2015) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Year /Region 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 CAGR% RIT Figures, 2011 North America XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX Europe XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX Asia-Pacific XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX Rest of World XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX Total XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX

Analysis by Technology Stem Cell Transplantation Stem cell transplant is a complicated practice, which involves substitution of diseased stem cells with healthy ones. It is important to analyze the hurdles that arise in this process to accomplish this task effectively. Market Overview

MIR005 Stem Cell Research A Market Insight Report, January 2011 RI Technologies, www.researchimpact.com Sample Page - 5

Global market for Stem Cell (SC) Transplantation is projected to reach US$ XX.XX billion by 2015 from an estimated US$ XX.XX billion in 2009, registering a CAGR of XX.XX % during the analysis period 2005-2015. North American SC Transplantation market was estimated at US$ XX.XX billion in 2009 to represent the largest market with a share of XX.XX %. Growing at a CAGR of XX.XX % during the period 2005-2015, North America is further projected to retain the leading position with market worth US$ XX.XX billion in the year 2015. Europe represents the second largest SC Transplantation market with an estimated US$5 XX.XX billion in 2009 and is projected to reach the value of US$ XX.XX billion by 2015. Asia-Pacific is projected to be the fastest growing market during the analysis period with a CAGR of XX.XX %. Exhibit: Stem Cell Transplantation Global Value Market Estimations & Predictions (2005-2015) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million
Year/Region 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 CAGR %
RIT Figures, 2011

North America XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX

Europe XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX

AsiaPacific XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX

Rest of World XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX

Total XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX

MIR005 Stem Cell Research A Market Insight Report, January 2011 RI Technologies, www.researchimpact.com Sample Page - 6

Exhibit: List of Major Global Companies

S.No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 More Company Aastrom Biosciences, Inc. Advanced Cell Technology, Inc. Aldagen, Inc. AmStem Corporation Angel BioTechnology Holdings PLC ArunA Biomedical, Inc. Athersys, Inc. Beike Biotechnology Co., Ltd. BioE, Inc. Biomaster, Inc. BioTime, Inc. BrainStorm Cell Therapeutics, Inc. California Stem Cell, Inc. Cell Care Pty. Ltd. Cellartis AB Cellerant Therapeutics, Inc. Cellerix SA Cells4Life Ltd. Cellular Dynamics International Country USA USA USA USA UK USA USA China USA Japan USA USA USA Australia Sweden USA Spain UK USA Website www.aastrom.com www.advancedcell.com www.aldagen.com www.amsteminc.com www.angelbio.com www.arunabiomedical.co m www.athersys.com www.beikebiotech.com www.bioe.com www.biomaster.jp www.biotimeinc.com www.brainstorm-cell.com www.californiastemcell.c om www.cellcareaustralia.co m.au www.cellartis.com www.cellerant.com www.cellerix.com www.cells4life.co.uk www.cellulardynamics.co m

RIT, 2011

Exhibit: Global Private Cord Blood Banks by Geographic Region (2009)

Region % Breakdow n 29.45 26.03 21.92 15.07 5.48 2.05 100.00

North America Europe Asia-Pacific Latin America Middle East South Africa Total
RIT Figures,

MIR005 Stem Cell Research A Market Insight Report, January 2011 RI Technologies, www.researchimpact.com Sample Page - 7

2011

STEM CELL RESEARCH - THE INDUSTRY OUTLOOK

Stem cell research has picked up pace like never before now. The technology is leading to a new kind of cell-based medicine that regenerative in nature. However, practicality and ethics dominate the ever controversial subject. Hence, it may take some more time, before a proper worldwide consensus emerges on the usage and procedures of stem cell research. While some countries approve, some oppose. Stem cell research is most likely to gather pace in countries with less regulatory controls. Of all the countries, China has the most favorable environment for research. The UK too has a strong research presence. The United States is the leader in stem cell research. However, the government controls the grants for research but places no restrictions on funds from private, state, or local government resources. The global stem cell research market is projected to reach about US$ XX.XX billion by the year 2015 at a CAGR of about XX.XX % from a market of about US$ XX.XX billion in 2009. Adult stem cells market is the largest tapped market while cord blood and embryonic stem cell markets, though with huge market potential, are still in infancy stages. The US is the leader followed by the European and Asia-Pacific regions. With government regulations being amended in several countries, stem cell research is expected to pick up pace rapidly in the next few years. Countries are competing globally for getting an edge in stem cell research as breakthrough technologies in this field would herald the countrys medical expertise and dominance. Research and laboratory technologies are also progressing rapidly. The potential of stem cell research both medically and economically, is leading to huge investments by biotechnology companies, pharmaceutical companies and governments too..

http://www.researchimpact.c om/

MIR005 Stem Cell Research A Market Insight Report, January 2011 RI Technologies, www.researchimpact.com Sample Page - 8